Is C4 Therapeutics Inc (CCCC) Stock a Smart Investment Tuesday?

C4 Therapeutics Inc (CCCC) stock has fallen -84.19% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CCCC stock a score of 34 out of a possible 100.

That rank is chiefly influenced by a long-term technical score of 3. CCCC's rank also includes a short-term technical score of 5.

CCCC has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CCCC!

See Full CCCC Report

What's Happening with CCCC Stock Today

C4 Therapeutics Inc (CCCC) stock is down -9.75% while the S&P 500 is up 0.65% as of 9:55 AM on Tuesday, Oct 24. CCCC has fallen -$0.15 from the previous closing price of $1.54 on volume of 97,549 shares. Over the past year the S&P 500 has risen 11.78% while CCCC has fallen -84.19%. CCCC lost -$2.85 per share in the over the last 12 months. Click Here to get the full Stock Report for C4 Therapeutics Inc stock.